SLXNW insider buying & filings

SLXNWSilexion Therapeutics Corp

—

15 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Feb 25 · scanned 8m ago

No price data yet — the yfinance scanner hasn't produced bars for SLXNW.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Feb 25GRANTNoy ShlomoDirectorindirect9,091 sh—

Feb 23GRANTShirvan MitchellCSO and CDOdirect49,726 sh—

Feb 23GRANTPeled AmnonDirectordirect7,576 sh—

Feb 23GRANTLushi AvnerDirectorindirect9,091 sh—

Feb 23GRANTHorenshtein Hadar MiritCFO and Secretarydirect49,726 sh—

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice